Pill Penalty Provisions Will Have a Chilling Effect on the Prescription Ecosystem
Biosimilar Resources
Price Setting Impact on Biosimilar Innovators and Manufacturers
House-Proposed
Bill Resources
Expanded Drug Pricing Controls Lead to 1.2M Jobs Lost and Threaten Billions in Medical Research Funding
March-In
Resources
Exercising so-called march-in rights is the most recent attempt at undermining U.S. leadership in healthcare innovation. This threatens the public-private partnership that has been essential to delivering new medicines to patients for decades.